Improvement of common cold with Pycnogenol®: a Winter registry study

Area of Science:

• Natural Product Research
• Immunology
• Public Health

Background:

• The common cold presents significant health and economic burdens.
• Pycnogenol® (pine bark extract) possesses anti-inflammatory, antioxidant, and anti-edema properties.
• Natural compounds are increasingly explored for managing cold symptoms.

Purpose of the Study:

• To evaluate Pycnogenol®'s efficacy in reducing common cold symptoms.
• To assess the impact of Pycnogenol® on the duration of illness.
• To determine Pycnogenol®'s role in preventing cold-related complications.

Main Methods:

• A registry study involving 146 otherwise healthy subjects.
• One group received Pycnogenol® (50 mg, twice daily) alongside standard cold management.
• A control group received standard cold management only.

Main Results:

• Pycnogenol® supplementation reduced perceived cold duration (3.1 vs. 4.2 days).
• Significantly fewer lost workdays were observed in the Pycnogenol® group.
• Pycnogenol® decreased the need for over-the-counter medications and prevented complications.

Conclusions:

• Pycnogenol® supplementation appears to alleviate common cold symptoms.
• The study suggests Pycnogenol® can shorten the course of the common cold.
• Pycnogenol® demonstrated potential in preventing cold complications.